Insulin Lispro Aabc + Octreotide Interaction
Moderateinteraction on record
Description
Somatostatin analog that may increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin lispro-aabc
Somatostatin analog that may increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin lispro-aabc